Medical Economics September 24, 2024
The evolving criteria for coverage mean physicians will need to stay informed and help patients navigate their options during Medicare Open Enrollment
Older obese Americans may soon gain Medicare coverage for the weight-loss medication semaglutide, potentially reducing their high risk of heart disease. However, the criteria for eligibility, the number of people who will qualify, and the financial impact on Medicare remain under debate.
A study published in the Annals of Internal Medicine, led by Alexander Chaitoff, M.D., of the VA Ann Arbor Healthcare System and University of Michigan, examined how semaglutide coverage could affect the health care system. Depending on how Medicare and its affiliated insurance plans define eligibility, the number of beneficiaries and the cost could vary widely,...